The Best Fish Oil
Fish oil at a dose you could actually get from food, tested for twelve weeks in trained adults. Here is what changed and what did not.
The straight answer, up front
Buy on EPA and DHA per serving, not on the size of the capsule or the number on the front of the bottle.
That is the whole skill. A 1000 mg fish oil capsule is not 1000 mg of the stuff that does anything. It is 1000 mg of oil, of which the active omega-3s are a fraction, and that fraction varies enormously between products.
Flip the bottle over and find the two numbers that matter: EPA and DHA. Everything else on the label is packaging.
What a proper trial in trained people found
Thirty-eight physically trained adults, training at least five days a week, completed a 12-week double-blind placebo-controlled matched-pair trial. The control group took high-oleic acid tablets. The DHA group took 715 mg per day of microencapsulated DHA.
Participants did eccentric cycling at week 0 and again at week 12, with assessments before, immediately after, 24 hours after and 48 hours after. Eccentric work is used in these studies because it reliably produces muscle damage and soreness.
The primary outcomes were delayed onset muscle soreness, measured on a visual analogue scale, and the Omega-3 Index, measured by finger-stick blood spot.
The Omega-3 Index was equal between groups at the start and elevated in the DHA group by the end, a difference of 2.43 percent with a confidence interval of 2.10 to 2.77.
And the conclusion: a dietary achievable dose of DHA elevated the Omega-3 Index and reduced soreness in physically trained adults.
That last phrase, dietary achievable, matters. This was not a megadose. It is a level you could plausibly reach through food or a sensible supplement.
Thirty-eight participants across two unequally sized groups, 12 control and 26 DHA, is a modest trial. But it is double-blind, placebo-controlled, twelve weeks long, and conducted in exactly the population reading this.
The number to actually track
The Omega-3 Index is the useful concept here. It measures the proportion of omega-3 in your red blood cell membranes, so it reflects your status over time rather than what you swallowed this morning.
The trial measured it with a finger-stick dried blood spot, which is a simple test.
The practical consequence: your supplement is a means to a status, not an end in itself. If you eat oily fish regularly you may already be there and gain little from a capsule. If you never eat fish, you are the person most likely to see a change.
What else it may do
A systematic review and meta-analysis following PRISMA guidelines searched three databases for randomised controlled trials on omega-3 supplementation and heart rate variability in overweight and obese participants.
Heart rate variability is a non-invasive marker of autonomic balance and is associated with cardiovascular risk. The primary outcomes were time-domain measures including RMSSD and SDNN.
The review exists because the effect in this population was unclear, and it set out to explore heterogeneity across study designs.
I include it to mark the boundary rather than to sell you anything. That analysis was conducted in overweight and obese participants, which is not the same as trained lifters, and heart rate variability is a marker rather than an outcome you feel.
The long game nobody buys it for
One more piece of context, because it reframes what this supplement is.
A review systematically synthesised evidence on n-3 polyunsaturated fatty acids and sarcopenia, the age-related loss of muscle mass, strength and function. It searched four databases and included interventional studies, observational studies and high-quality reviews, examining anti-inflammatory, antioxidant and metabolic mechanisms including muscle satellite cells and oxidative stress.
It describes omega-3s as a promising nutritional strategy for mitigating that muscle loss.
Promising is the operative word, and this is a mechanistic review rather than a trial in young lifters. But it points at why the Omega-3 Index is worth caring about beyond next-day soreness. The thing you are managing is a long-term status, not a session.
How I would actually choose
First, EPA and DHA per serving. Add the two numbers. Compare products on that, and on how many capsules you need to swallow to get there. The trial above used 715 mg of DHA daily, which is a reasonable reference point.
Second, cost per gram of EPA plus DHA, not cost per bottle. This is where cheap products stop being cheap, because you need three capsules to match one of something else.
Third, freshness. Fish oil oxidises, which is what makes it taste and smell rancid. Look for a product with a manufacturing or expiry date you can read, and if capsules smell strongly off when you open one, that is information.
Fourth, form. The trial used microencapsulated DHA specifically. Encapsulation is a way of protecting the oil, which is a reasonable thing to pay for if it keeps the product stable.
Fifth, ignore the health claims on the front. Buy on the two numbers on the back.
Who probably does not need it
If you eat oily fish a couple of times a week, you are likely getting meaningful EPA and DHA from food already.
The trial's own framing, a dietary achievable dose, is the clue. The dose that worked is one you could reach by eating.
A supplement is a convenience for people who do not eat fish. It is not a separate category of intervention.
Buy on EPA and DHA per serving and on cost per gram of those two combined, not on capsule size or front-of-bottle claims. A twelve-week double-blind placebo-controlled trial in adults training five or more days a week found 715 mg of DHA daily raised the Omega-3 Index by 2.43 percent and reduced delayed onset muscle soreness, at what the authors called a dietary achievable dose. That last point cuts both ways: if you already eat oily fish regularly you may be getting there through food. Watch for oxidation, ignore the marketing, and read the back of the bottle.
Limits of this evidence
- The DHA trial included 38 participants split unevenly (12 control, 26 DHA), which is a modest sample for detecting effects reliably.
- It tested microencapsulated DHA specifically rather than standard fish oil capsules, so the results may not transfer directly to every product on the shelf.
- It used eccentric cycling to induce muscle damage, which is a laboratory model rather than normal resistance training.
- Soreness was measured on a visual analogue scale, which is subjective by nature.
- The heart rate variability meta-analysis studied overweight and obese participants, so it does not apply directly to trained lifters, and heart rate variability is an intermediate marker rather than a clinical outcome.
- No source here tested product quality, oxidation levels or label accuracy across brands, so the buying guidance on freshness and cost per gram is practical reasoning rather than a research finding.
- This article is editorial and not medical advice, and omega-3 supplements can interact with some medications.
- Each claim rests on a single source with no independent replication checked. Treat the piece as provisional.
Sources (3)
- Microencapsulated docosahexaenoic acid increases the Omega-3 Index and attenuates the physiological impact of eccentric exercise in physically trained adults: a 12-week double-blind placebo-controlled trial. European Journal of Nutrition, 2026
- Effects of omega-3 fatty acid supplementation on heart rate variability. World Journal of Clinical Pediatrics, 2026
- n-3 Polyunsaturated Fatty Acids and Sarcopenia: Recent Advances and Mechanistic Research. Nutrients, 2026